Scarica l'app Stockscreener
197.73
2.41%
-5.30
Precedente Chiudi:
$203.03
Aprire:
$201.01
Volume 24 ore:
1.11M
Relative Volume:
0.99
Capitalizzazione di mercato:
$27.58B
Reddito:
$2.12B
Utile/perdita netta:
$-309.19M
Rapporto P/E:
-86.57
EPS:
-2.2841
Flusso di cassa netto:
$93.57M
1 W Prestazione:
-8.32%
1M Prestazione:
+0.53%
6M Prestazione:
+17.92%
1 anno Prestazione:
+33.94%
Intervallo 1D:
$193.85
$203.28
Intervallo di 1 settimana:
$192.59
$212.99
Portata 52W:
$125.38
$256.36
Natera Inc Stock (NTRA) Company Profile
Nome
Natera Inc
Settore
Industria
Telefono
650-249-9090
Indirizzo
13011 MCCALLEN PASS, AUSTIN, CA
Compare NTRA vs TMO, DHR, IDXX, A, WAT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
197.81 | 28.31B | 2.12B | -309.19M | 93.57M | -2.2841 |
|
TMO
Thermo Fisher Scientific Inc
|
518.75 | 192.62B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
201.85 | 144.77B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
619.49 | 51.65B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
118.45 | 34.09B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
317.77 | 31.30B | 3.17B | 642.63M | 516.49M | 10.77 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-07 | Iniziato | Citigroup | Buy |
| 2025-12-02 | Ripresa | Morgan Stanley | Overweight |
| 2025-10-27 | Aggiornamento | BNP Paribas Exane | Underperform → Neutral |
| 2025-09-22 | Ripresa | Wells Fargo | Equal Weight |
| 2025-03-13 | Iniziato | RBC Capital Mkts | Outperform |
| 2025-01-23 | Iniziato | Barclays | Overweight |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-04-08 | Ripresa | Craig Hallum | Buy |
| 2024-02-20 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2023-12-29 | Reiterato | BTIG Research | Buy |
| 2023-12-14 | Iniziato | Guggenheim | Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-11-13 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2023-09-28 | Iniziato | Bernstein | Mkt Perform |
| 2023-07-05 | Ripresa | JP Morgan | Overweight |
| 2023-05-05 | Iniziato | UBS | Buy |
| 2023-01-18 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-04-25 | Iniziato | Stephens | Overweight |
| 2022-03-08 | Iniziato | Goldman | Buy |
| 2022-01-06 | Ripresa | Piper Sandler | Overweight |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-06-15 | Iniziato | Raymond James | Mkt Perform |
| 2021-05-25 | Iniziato | Wells Fargo | Overweight |
| 2021-01-28 | Iniziato | Truist | Buy |
| 2020-10-08 | Iniziato | BTIG Research | Buy |
| 2020-09-28 | Iniziato | Morgan Stanley | Overweight |
| 2020-09-17 | Iniziato | SVB Leerink | Outperform |
| 2020-06-10 | Ripresa | Piper Sandler | Overweight |
| 2020-05-07 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-10-05 | Iniziato | JP Morgan | Neutral |
| 2018-07-05 | Reiterato | Piper Jaffray | Overweight |
| 2017-08-07 | Reiterato | Morgan Stanley | Overweight |
| 2016-11-10 | Reiterato | The Benchmark Company | Buy |
| 2016-05-23 | Reiterato | The Benchmark Company | Buy |
| 2016-05-11 | Reiterato | The Benchmark Company | Buy |
| 2016-04-19 | Iniziato | The Benchmark Company | Buy |
| 2015-09-28 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2015-08-14 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2015-08-04 | Iniziato | Robert W. Baird | Outperform |
| 2015-07-27 | Iniziato | Morgan Stanley | Equal-Weight |
| 2015-07-27 | Iniziato | Piper Jaffray | Overweight |
| 2015-07-27 | Iniziato | Wedbush | Neutral |
Mostra tutto
Natera Inc Borsa (NTRA) Ultime notizie
Victory Capital Management Inc. Sells 165,275 Shares of Natera, Inc. $NTRA - MarketBeat
Pura Vida Investments LLC Has $402,000 Stake in Natera, Inc. $NTRA - MarketBeat
Natera, Inc. $NTRA Shares Sold by GW&K Investment Management LLC - MarketBeat
ARK Investment Management LLC Decreases Stake in Natera, Inc. $NTRA - MarketBeat
Amova Asset Management Americas Inc. Has $101.13 Million Holdings in Natera, Inc. $NTRA - MarketBeat
Natera at Raymond James Conference: Strategic Growth and Innovation - Investing.com
How Natera’s 2025 Results and SINERGY Trial Data May Shape Natera (NTRA) Investors’ Expectations - simplywall.st
Signatera Oncology Test Drives Natera’s (NTRA) Growth - Insider Monkey
Signatera Oncology Test Drives Natera's (NTRA) Growth - Bitget
Picton Mahoney Asset Management Sells 17,139 Shares of Natera, Inc. $NTRA - MarketBeat
Insider Sell: Steven Chapman Sells Shares of Natera Inc (NTRA) - GuruFocus
Natera (NASDAQ:NTRA) CEO Steven Leonard Chapman Sells 3,950 Shares - MarketBeat
Solomon Moshkevich Sells 3,000 Shares of Natera (NASDAQ:NTRA) Stock - MarketBeat
Jonathan Sheena of Natera (NTRA) logs stock sales and new 2,103 RSU grant - Stock Titan
Natera (NTRA) president John Fesko awarded 10,051 RSUs in stock grant - Stock Titan
CFO at Natera (NTRA) receives 10,051 stock-based RSU award - Stock Titan
Natera (NTRA) Stock Trades Up, Here Is Why - Finviz
Morgan Stanley Lowers Price Target for Natera (NTRA) to $250 | N - GuruFocus
Natera (NASDAQ:NTRA) Price Target Lowered to $250.00 at Morgan Stanley - MarketBeat
Strive Asset Management LLC Invests $1.61 Million in Natera, Inc. $NTRA - MarketBeat
Morgan Stanley Cuts Price Target on Natera to $250 From $265, Keeps Overweight Rating - marketscreener.com
Rafferty Asset Management LLC Has $7.63 Million Stock Holdings in Natera, Inc. $NTRA - MarketBeat
Morgan Stanley cuts Natera stock price target on model update - Investing.com Australia
NTRA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Morgan Stanley cuts Natera stock price target on model update By Investing.com - Investing.com UK
Steven L. Chapman sells large NTRA stake (NASDAQ: NTRA) via broker - Stock Titan
Solomon Moshkevich proposes sale — NTRA (NASDAQ: NTRA) - Stock Titan
Canaccord reiterates Natera stock Buy rating after strong quarter By Investing.com - Investing.com South Africa
Canaccord reiterates Natera stock Buy rating after strong quarter - Investing.com
Natera, Inc. (NTRA) Stock Analysis: A 25% Upside Potential With Strong Buy Ratings - DirectorsTalk Interviews
Natera, Inc. $NTRA Shares Acquired by DNB Asset Management AS - MarketBeat
Mitsubishi UFJ Asset Management Co. Ltd. Acquires 8,630 Shares of Natera, Inc. $NTRA - MarketBeat
American Century Companies Inc. Buys 238,679 Shares of Natera, Inc. $NTRA - MarketBeat
Natera, Inc. $NTRA Shares Purchased by TD Asset Management Inc - MarketBeat
Handelsbanken Fonder AB Has $21.14 Million Stock Holdings in Natera, Inc. $NTRA - MarketBeat
Assessing Natera (NTRA) Valuation After Recent Share Price Pullback And Long Term Return Strength - Yahoo Finance
Artisan Partners Limited Partnership Raises Holdings in Natera, Inc. $NTRA - MarketBeat
NTRA SEC FilingsNatera Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Forecasting The Future: 10 Analyst Projections For Natera - Sahm
Natera, Inc. (NASDAQ:NTRA) Q4 2025 Earnings Call Transcript - Insider Monkey
Erste Asset Management GmbH Purchases 20,000 Shares of Natera, Inc. $NTRA - MarketBeat
Natera (NTRA) Q4 Profit Sparks Questions Around Bullish Earnings Turnaround Narrative - simplywall.st
3 Reasons Exelixis Stock Could Deliver Market‑Beating Returns Over the Next Decade - The Motley Fool
Citigroup Inc. Sells 73,833 Shares of Natera, Inc. $NTRA - MarketBeat
Decoding Natera Inc (NTRA): A Strategic SWOT Insight - GuruFocus
NTRA Should I Buy - Intellectia AI
NTRA PE Ratio & Valuation, Is NTRA Overvalued - Intellectia AI
Natera (NASDAQ:NTRA) Posts Quarterly Earnings Results, Beats Expectations By $0.81 EPS - MarketBeat
Natera Presents Signatera MRD Data at ASCO GU Showcasing Potential Across GU Cancers - National Today
NTRA: Baird Raises Price Target to $257 with Outperform Rating | - GuruFocus
NTRA: Wells Fargo Maintains Rating, Raises Price Target to $215 - GuruFocus
Natera Inc Azioni (NTRA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Natera Inc Azioni (NTRA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Chapman Steven Leonard | CEO AND PRESIDENT |
Mar 02 '26 |
Sale |
200.02 |
3,950 |
790,095 |
156,607 |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Mar 02 '26 |
Option Exercise |
9.59 |
5,125 |
49,149 |
153,023 |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Mar 02 '26 |
Sale |
199.85 |
3,000 |
599,545 |
150,023 |
1.85%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):